ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis.

October 24, 2008

DCPC Board Okays Concept For $10 Mil. Program to Promote Cancer Management In Rural Areas

May 25, 1990

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989

CTCs Do Not Affect Survival, But Could Signal Metastases

December 30, 2011

NCI Cooperative Group Clinical Trials Approved

September 24, 2010